dehydroepiandrosterone has been researched along with Cardiovascular Diseases in 68 studies
Dehydroepiandrosterone: A major C19 steroid produced by the ADRENAL CORTEX. It is also produced in small quantities in the TESTIS and the OVARY. Dehydroepiandrosterone (DHEA) can be converted to TESTOSTERONE; ANDROSTENEDIONE; ESTRADIOL; and ESTRONE. Most of DHEA is sulfated (DEHYDROEPIANDROSTERONE SULFATE) before secretion.
dehydroepiandrosterone : An androstanoid that is androst-5-ene substituted by a beta-hydroxy group at position 3 and an oxo group at position 17. It is a naturally occurring steroid hormone produced by the adrenal glands.
Cardiovascular Diseases: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The age-related decline in serum dehydroepiandrosterone (DHEA) and its sulfated ester (DHEA-S) has suggested that a relative deficiency of these steroids may be causally related to the development of chronic diseases generally associated with aging, including insulin resistance, obesity, cardiovascular disease, cancer, reductions of the immune defense, depression and a general deterioration in the sensation of well-being." | 8.82 | Dehydroepiandrosterone, obesity and cardiovascular disease risk: a review of human studies. ( Labrie, F; Tchernof, A, 2004) |
| "Obesity is a heterogeneous condition and not every obese patient is at increased risk of cardiovascular diseases (CVD)." | 6.39 | Obesity and metabolic complications: contribution of dehydroepiandrosterone and other steroid hormones. ( Bélanger, A; Després, JP; Labrie, F; Tchernof, A, 1996) |
| "The age-related decline in serum dehydroepiandrosterone (DHEA) and its sulfated ester (DHEA-S) has suggested that a relative deficiency of these steroids may be causally related to the development of chronic diseases generally associated with aging, including insulin resistance, obesity, cardiovascular disease, cancer, reductions of the immune defense, depression and a general deterioration in the sensation of well-being." | 4.82 | Dehydroepiandrosterone, obesity and cardiovascular disease risk: a review of human studies. ( Labrie, F; Tchernof, A, 2004) |
| " Dehydroepiandrosterone (DHEA) protects against cardiovascular diseases, but results among previous studies have been inconsistent." | 3.83 | Dehydroepiandrosterone-sulfate is associated with cardiovascular reactivity to stress in women. ( Hirokawa, K; Imano, H; Iso, H; Kajiura, M; Kitamura, A; Kiyama, M; Nagayoshi, M; Ohira, T; Okada, T, 2016) |
| "Dehydroepiandrosterone exerts a protective effect against cardiovascular diseases." | 3.78 | Correlation of circulating dehydroepiandrosterone with activated protein C generation and carotid intima-media thickness in male patients with type 2 diabetes. ( Akatsuka, H; Gabazza, EC; Hayashi, T; Maruyama-Furuta, N; Matsumoto, K; Onishi, Y; Sakamoto, M; Sasaki, R; Sumida, Y; Suzuki, T; Takei, Y; Uemura, M; Yano, Y; Yasuma, T, 2012) |
| "A major achievement from 500 million years of evolution is the establishment of a high secretion rate of dehydroepiandrosterone (DHEA) by the human adrenal glands coupled with the indroduction of menopause which stops secretion of estrogens by the ovary." | 3.76 | DHEA, important source of sex steroids in men and even more in women. ( Labrie, F, 2010) |
| " We examined the possible associations of sex hormone-binding globulin, total and free testosterone, estradiol, and dehydroepiandrosterone sulfate to Lp(a) concentrations in men in two population-based studies (San Antonio Heart Study [n = 178] and a Finnish study on the association between insulin resistance and atherosclerosis [n = 87])." | 3.69 | Lack of association between sex hormones and Lp(a) concentrations in American and Finnish men. ( Gruber, KK; Haffner, SM; Laakso, M; Mykkanen, L; Rainwater, DL, 1994) |
| "It has been postulated that dehydroepiandrosterone (DHEA) and its sulfate ester, dehydroepiandrosterone sulfate (DHEAS), the major secretory products of the human adrenal gland, may be discriminators of life expectancy and aging." | 3.67 | A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease. ( Barrett-Connor, E; Khaw, KT; Yen, SS, 1986) |
| "Insulin sensitivity was estimated using the insulin sensitivity index and the quantitative insulin sensitivity check index, whereas insulin resistance was estimated using the homeostatic model for insulin resistance." | 2.79 | Association between circulating endogenous androgens and insulin sensitivity changes with exercise training in midlife women. ( Campbell, C; Gaikwad, NW; Gustafson, MB; Keim, NL; Krishnan, S, 2014) |
| "A systematic review and dose-response meta-analysis of randomized controlled trials (RCTs) was performed employing in Scopus, PubMed/Medline, Web of Science, Embase and Google Scholar, then including relevant articles that addressed the effects of DHEA supplementation on the lipid profile, up to February 2020." | 2.66 | Effects of dehydroepiandrosterone (DHEA) supplementation on the lipid profile: A systematic review and dose-response meta-analysis of randomized controlled trials. ( Khani, V; O Santos, H; Qin, Y; Tan, SC; Zhi, Y, 2020) |
| " New preparations are being developed to better mimic normal physiological cortisol levels with convenient, once-daily dosing which may improve treatment outcomes." | 2.49 | Therapy of endocrine disease: Perspectives on the management of adrenal insufficiency: clinical insights from across Europe. ( Grossman, A; Johannsson, G; Quinkler, M; Zelissen, P, 2013) |
| "Dehydroepiandrosterone (DHEA) is a steroid hormone derived from cholesterol synthesized by the adrenal glands." | 2.49 | Role of DHEA in cardiovascular diseases. ( Dumas de la Roque, E; Marthan, R; Savineau, JP, 2013) |
| "Dehydroepiandrosterone (DHEA) is a multifunctional steroid with a broad range of biological effects in humans and animals." | 2.48 | Oxidative metabolism of dehydroepiandrosterone (DHEA) and biologically active oxygenated metabolites of DHEA and epiandrosterone (EpiA)--recent reports. ( El Kihel, L, 2012) |
| " This paper includes practical considerations on dosage to be used, contraindications and follow-up." | 2.42 | Androgen therapy with dehydroepiandrosterone. ( Buvat, J, 2003) |
| "In some breast cancer cell lines in a low oestrogen milieu DHEA has an oestradiol-like effect, stimulating tumour growth, whereas in oestradiol abundance DHEA antagonises the growth-stimulating effect of oestradiol." | 2.39 | Physiological importance of dehydroepiandrosterone. ( Ebeling, P; Koivisto, VA, 1994) |
| "Obesity is a heterogeneous condition and not every obese patient is at increased risk of cardiovascular diseases (CVD)." | 2.39 | Obesity and metabolic complications: contribution of dehydroepiandrosterone and other steroid hormones. ( Bélanger, A; Després, JP; Labrie, F; Tchernof, A, 1996) |
| "All deaths due to cancer (n = 1040), cardiovascular diseases (n = 598), and all causes (n = 2407) that occurred in EPIC-Heidelberg until end of 2014 were included." | 1.91 | Dehydroepiandrosterone Sulfate and Mortality in Middle-Aged and Older Men and Women-A J-shaped Relationship. ( Johnson, T; Kaaks, R; Katzke, V; Mukama, T, 2023) |
| "Sex influenced the effect of having PTSD on LDL with only male patients having lower values than male controls (p=0." | 1.46 | Plasma lipoproteins in posttraumatic stress disorder patients compared to healthy controls and their associations with the HPA- and HPT-axis. ( Assies, J; Mocking, R; Olff, M; Schene, A; Vries, GJ, 2017) |
| "DHEAS was not associated with CVD or ischemic heart disease (IHD) deaths in age-adjusted analyses where the comparison group was individuals without CVD or IHD death." | 1.29 | The epidemiology of DHEAS and cardiovascular disease. ( Barrett-Connor, E; Goodman-Gruen, D, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (5.88) | 18.7374 |
| 1990's | 18 (26.47) | 18.2507 |
| 2000's | 18 (26.47) | 29.6817 |
| 2010's | 22 (32.35) | 24.3611 |
| 2020's | 6 (8.82) | 2.80 |
| Authors | Studies |
|---|---|
| Islam, RM | 1 |
| Bell, RJ | 1 |
| Handelsman, DJ | 1 |
| McNeil, JJ | 1 |
| Nelson, MR | 1 |
| Reid, CM | 1 |
| Tonkin, AM | 1 |
| Wolfe, RS | 1 |
| Woods, RL | 1 |
| Davis, SR | 1 |
| Kazzi, B | 1 |
| Ogunmoroti, O | 1 |
| Rodriguez, CP | 1 |
| Zhao, D | 2 |
| Minhas, AS | 1 |
| Osibogun, O | 1 |
| Subramanya, V | 2 |
| Allison, MA | 2 |
| Ouyang, P | 3 |
| Michos, ED | 3 |
| Mukama, T | 2 |
| Johnson, T | 2 |
| Katzke, V | 2 |
| Kaaks, R | 2 |
| Araujo-Castro, M | 1 |
| Hanzu, FA | 1 |
| Pascual-Corrales, E | 1 |
| García Cano, AM | 1 |
| Marchan, M | 1 |
| Escobar-Morreale, HF | 1 |
| Valderrabano, P | 1 |
| Casals, G | 1 |
| Teixeira, CJ | 1 |
| Veras, K | 1 |
| de Oliveira Carvalho, CR | 1 |
| Qin, Y | 1 |
| O Santos, H | 1 |
| Khani, V | 1 |
| Tan, SC | 1 |
| Zhi, Y | 1 |
| Vries, GJ | 1 |
| Mocking, R | 1 |
| Assies, J | 1 |
| Schene, A | 1 |
| Olff, M | 1 |
| Meun, C | 1 |
| Franco, OH | 1 |
| Dhana, K | 1 |
| Jaspers, L | 1 |
| Muka, T | 1 |
| Louwers, Y | 1 |
| Ikram, MA | 1 |
| Fauser, BCJM | 1 |
| Kavousi, M | 1 |
| Laven, JSE | 1 |
| Blaslov, K | 1 |
| Kruljac, I | 1 |
| Mirošević, G | 1 |
| Kirigin Biloš, LS | 1 |
| Vrkljan, M | 1 |
| Guallar, E | 1 |
| Vaidya, D | 2 |
| Ndumele, CE | 1 |
| Lima, JA | 1 |
| Shah, SJ | 1 |
| Bertoni, AG | 1 |
| Budoff, MJ | 1 |
| Post, WS | 1 |
| Mannella, P | 1 |
| Simoncini, T | 1 |
| Caretto, M | 1 |
| Genazzani, AR | 3 |
| Kellner, M | 1 |
| Muhtz, C | 1 |
| Weinås, Å | 1 |
| Ćurić, S | 1 |
| Yassouridis, A | 1 |
| Wiedemann, K | 1 |
| Di Dalmazi, G | 1 |
| Fanelli, F | 1 |
| Zavatta, G | 1 |
| Ricci Bitti, S | 1 |
| Mezzullo, M | 1 |
| Repaci, A | 1 |
| Pelusi, C | 1 |
| Gambineri, A | 1 |
| Altieri, P | 1 |
| Mosconi, C | 1 |
| Balacchi, C | 1 |
| Golfieri, R | 1 |
| Cosentino, ER | 1 |
| Borghi, C | 1 |
| Vicennati, V | 1 |
| Pasquali, R | 1 |
| Pagotto, U | 1 |
| Grossman, A | 1 |
| Johannsson, G | 1 |
| Quinkler, M | 1 |
| Zelissen, P | 1 |
| Krishnan, S | 1 |
| Gustafson, MB | 1 |
| Campbell, C | 1 |
| Gaikwad, NW | 1 |
| Keim, NL | 1 |
| Ohlsson, C | 2 |
| Vandenput, L | 2 |
| Tivesten, A | 2 |
| Goodarzi, MO | 1 |
| Carmina, E | 1 |
| Azziz, R | 1 |
| Berger, M | 1 |
| Juster, RP | 1 |
| Sarnyai, Z | 1 |
| Hirokawa, K | 1 |
| Ohira, T | 1 |
| Nagayoshi, M | 1 |
| Kajiura, M | 1 |
| Imano, H | 1 |
| Kitamura, A | 1 |
| Kiyama, M | 1 |
| Okada, T | 1 |
| Iso, H | 1 |
| Pluchino, N | 1 |
| Boxer, RS | 1 |
| Kleppinger, A | 1 |
| Brindisi, J | 1 |
| Feinn, R | 1 |
| Burleson, JA | 1 |
| Kenny, AM | 1 |
| Labrie, F | 4 |
| Barrett-Connor, E | 6 |
| Karlsson, MK | 1 |
| Ljunggren, O | 1 |
| Mellström, D | 1 |
| Guay, A | 1 |
| Traish, A | 1 |
| Bhuiyan, MS | 1 |
| Fukunaga, K | 1 |
| Traish, AM | 1 |
| Kang, HP | 1 |
| Saad, F | 1 |
| Guay, AT | 1 |
| El Kihel, L | 1 |
| Suzuki, T | 1 |
| Yano, Y | 1 |
| Sakamoto, M | 1 |
| Uemura, M | 1 |
| Yasuma, T | 1 |
| Onishi, Y | 1 |
| Sasaki, R | 2 |
| Matsumoto, K | 1 |
| Hayashi, T | 1 |
| Maruyama-Furuta, N | 1 |
| Akatsuka, H | 1 |
| Gabazza, EC | 1 |
| Sumida, Y | 1 |
| Takei, Y | 1 |
| Savineau, JP | 1 |
| Marthan, R | 1 |
| Dumas de la Roque, E | 1 |
| Corrigan, B | 1 |
| Simon, HB | 1 |
| Skałba, P | 1 |
| Wójtowicz, M | 1 |
| Sikora, J | 1 |
| Buvat, J | 1 |
| Muller, M | 1 |
| van der Schouw, YT | 1 |
| Thijssen, JH | 1 |
| Grobbee, DE | 1 |
| Binello, E | 1 |
| Gordon, CM | 1 |
| Tchernof, A | 2 |
| Silvestri, A | 1 |
| Gambacciani, M | 1 |
| Vitale, C | 1 |
| Monteleone, P | 1 |
| Ciaponi, M | 1 |
| Fini, M | 1 |
| Mercuro, G | 1 |
| Rosano, GM | 1 |
| Cameron, DR | 1 |
| Braunstein, GD | 1 |
| Ryff, CD | 1 |
| Dienberg Love, G | 1 |
| Urry, HL | 1 |
| Muller, D | 1 |
| Rosenkranz, MA | 1 |
| Friedman, EM | 1 |
| Davidson, RJ | 1 |
| Singer, B | 1 |
| Kamel, NS | 1 |
| Gammack, J | 1 |
| Cepeda, O | 1 |
| Flaherty, JH | 1 |
| Bácsi, K | 1 |
| Kósa, J | 1 |
| Lazáry, A | 1 |
| Horváth, H | 1 |
| Balla, B | 1 |
| Lakatos, P | 2 |
| Speer, G | 1 |
| Raven, PW | 1 |
| Hinson, JP | 1 |
| Gapstur, SM | 1 |
| Schreiner, PJ | 1 |
| Golden, SH | 1 |
| Wong, ND | 1 |
| Criqui, MH | 1 |
| Andiran, N | 1 |
| Yordam, N | 1 |
| Halberg, F | 1 |
| Haffner, SM | 2 |
| Newcomb, PA | 1 |
| Marcus, PM | 1 |
| Klein, BE | 1 |
| Klein, R | 1 |
| Okamoto, K | 1 |
| Yagyu, K | 1 |
| Goodman-Gruen, D | 2 |
| Ebeling, P | 1 |
| Koivisto, VA | 1 |
| Vidal-Puig, A | 1 |
| García-Calvente, C | 1 |
| Muñoz Torres, M | 1 |
| Mykkanen, L | 1 |
| Gruber, KK | 1 |
| Rainwater, DL | 1 |
| Laakso, M | 1 |
| Casson, PR | 1 |
| Hornsby, PJ | 1 |
| Buster, JE | 1 |
| Khorram, O | 1 |
| Khaw, KT | 4 |
| Bélanger, A | 1 |
| Després, JP | 1 |
| Herrington, DM | 2 |
| Johannes, CB | 1 |
| Stellato, RK | 1 |
| Feldman, HA | 1 |
| Longcope, C | 1 |
| McKinlay, JB | 1 |
| Barna, I | 1 |
| Váradi, A | 1 |
| Roth, GS | 1 |
| Ingram, DK | 1 |
| Lane, MA | 1 |
| Szathmári, M | 1 |
| Vásárhelyi, B | 1 |
| Reusz, G | 1 |
| Tulassay, T | 1 |
| Rigaud, AS | 1 |
| Pellerin, J | 1 |
| Breckwoldt, M | 1 |
| Luppa, P | 1 |
| Munker, R | 1 |
| Nagel, D | 1 |
| Weber, M | 1 |
| Engelhardt, D | 1 |
| Nafziger, AN | 1 |
| Bush, TL | 1 |
| Yen, SS | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Aspirin in Reducing Events in the Elderly[NCT01038583] | 19,114 participants (Actual) | Observational | 2010-01-31 | Active, not recruiting | |||
| Phase III Study of Efficacy of High Dose Erythropoietin to Prevent Hypoxic-ischemic Encephalopathy Sequelae in Term Newborn[NCT01732146] | Phase 3 | 120 participants (Actual) | Interventional | 2013-03-28 | Completed | ||
| DHEA + Acolbifene Against Vasomotor Symptoms (Hot Flushes) in Postmenopausal Women (Placebo Controlled, Double Blind and Randomized Phase III Study to Evaluate the Effects of 12-Week Treatment With DHEA (Prasterone) and Acolbifene on Vasomotor Symptoms (H[NCT01452373] | Phase 3 | 238 participants (Actual) | Interventional | 2011-10-31 | Completed | ||
| Incidence of Diabetes and Cardiovascular Disease in Mexican Americans[NCT00005205] | 0 participants | Observational | 1987-08-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
30 reviews available for dehydroepiandrosterone and Cardiovascular Diseases
| Article | Year |
|---|---|
Dehydroepiandrosterone on metabolism and the cardiovascular system in the postmenopausal period.
Topics: Aged; Aged, 80 and over; Aging; Animals; Cardiovascular Diseases; Cardiovascular System; Dehydroepia | 2020 |
Effects of dehydroepiandrosterone (DHEA) supplementation on the lipid profile: A systematic review and dose-response meta-analysis of randomized controlled trials.
Topics: Adult; Aged; Biomarkers; Cardiovascular Diseases; Dehydroepiandrosterone; Dietary Supplements; Dysli | 2020 |
Therapy of endocrine disease: Perspectives on the management of adrenal insufficiency: clinical insights from across Europe.
Topics: Addison Disease; Adrenal Insufficiency; Cardiovascular Diseases; Circadian Rhythm; Dehydroepiandrost | 2013 |
DHEA and mortality: what is the nature of the association?
Topics: Adrenal Glands; Cardiovascular Diseases; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Fem | 2015 |
DHEA, DHEAS and PCOS.
Topics: Androgens; Animals; Body Mass Index; Cardiovascular Diseases; Dehydroepiandrosterone; Dehydroepiandr | 2015 |
Androgen replacement therapy and cardiovascular function.
Topics: Aging; Androgens; Cardiovascular Diseases; Cardiovascular System; Dehydroepiandrosterone; Female; Hu | 2009 |
Testosterone therapy in women with androgen deficiency: Its time has come.
Topics: Androgens; Breast Neoplasms; Cardiovascular Diseases; Clinical Trials as Topic; Dehydroepiandrostero | 2010 |
Targeting sigma-1 receptor signaling by endogenous ligands for cardioprotection.
Topics: Animals; Binding Sites; Cardiotonic Agents; Cardiovascular Diseases; Cardiovascular System; Cell Mem | 2011 |
Dehydroepiandrosterone (DHEA)--a precursor steroid or an active hormone in human physiology.
Topics: Aging; Animals; Body Composition; Bone and Bones; Cardiovascular Diseases; Dehydroepiandrosterone; D | 2011 |
Oxidative metabolism of dehydroepiandrosterone (DHEA) and biologically active oxygenated metabolites of DHEA and epiandrosterone (EpiA)--recent reports.
Topics: Androsterone; Animals; Brain; Cardiovascular Diseases; Dehydroepiandrosterone; Female; Humans; Hydro | 2012 |
Role of DHEA in cardiovascular diseases.
Topics: Age Factors; Animals; Cardiovascular Diseases; Dehydroepiandrosterone; Female; Humans; Hypertension, | 2013 |
DHEA and sport.
Topics: Adjuvants, Immunologic; Aging; Cardiovascular Diseases; Dehydroepiandrosterone; Exercise; Female; Hu | 2002 |
Androgen therapy with dehydroepiandrosterone.
Topics: Adjuvants, Immunologic; Adrenal Insufficiency; Aged; Aging; Cardiovascular Diseases; Cognition; Dehy | 2003 |
Endogenous sex hormones and cardiovascular disease in men.
Topics: Cardiovascular Diseases; Dehydroepiandrosterone; Humans; Male; Risk Factors; Testosterone | 2003 |
Clinical uses and misuses of dehydroepiandrosterone.
Topics: Adjuvants, Immunologic; Autoimmune Diseases; Cardiovascular Diseases; Clinical Trials as Topic; Dehy | 2003 |
Dehydroepiandrosterone, obesity and cardiovascular disease risk: a review of human studies.
Topics: Cardiovascular Diseases; Dehydroepiandrosterone; Humans; Obesity; Risk Factors | 2004 |
The use of dehydroepiandrosterone therapy in clinical practice.
Topics: Adrenal Insufficiency; Aging; Alzheimer Disease; Bone Density; Cardiovascular Diseases; Dehydroepian | 2005 |
Antioxidants and hormones as antiaging therapies: high hopes, disappointing results.
Topics: Aging; Antioxidants; Cardiovascular Diseases; Cerebrovascular Disorders; Cognition; Dehydroepiandros | 2006 |
[Significance of dehydroepiandrosterone and dehydroepiandrosterone sulfate in different diseases].
Topics: Androgens; Cardiovascular Diseases; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Diabetes | 2007 |
Dehydroepiandrosterone (DHEA) and the menopause: an update.
Topics: Adjuvants, Immunologic; Breast Neoplasms; Cardiovascular Diseases; Cognition Disorders; Dehydroepian | 2007 |
Quo vadis basic and clinical chronobiology: promise for health maintenance.
Topics: Adrenal Cortex; Alcoholism; Aldosterone; Biological Clocks; Blood Pressure; Breast Neoplasms; Cardio | 1983 |
Physiological importance of dehydroepiandrosterone.
Topics: Breast Neoplasms; Cardiovascular Diseases; Dehydroepiandrosterone; Female; Humans; Insulin Resistanc | 1994 |
[Adrenal androgens: traditionally forgotten hormones. Today, of current importance].
Topics: Adrenal Glands; Adrenocorticotropic Hormone; Androgens; Cardiovascular Diseases; Dehydroepiandroster | 1993 |
Adrenal androgens, insulin resistance, and cardiovascular disease.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Androgens; Cardiovascular Diseases; Dehydroepiandr | 1996 |
DHEA: a hormone with multiple effects.
Topics: Aged; Biomarkers; Bone Density; Brain; Cardiovascular Diseases; Dehydroepiandrosterone; Estrogen Rep | 1996 |
Dehydroepiandrosterone, dehydroepiandrosterone sulphate and cardiovascular disease.
Topics: Adult; Animals; Cardiovascular Diseases; Cholesterol; Cohort Studies; Dehydroepiandrosterone; Dehydr | 1996 |
Obesity and metabolic complications: contribution of dehydroepiandrosterone and other steroid hormones.
Topics: Adipose Tissue; Cardiovascular Diseases; Dehydroepiandrosterone; Female; Gonadal Steroid Hormones; H | 1996 |
Calorie restriction in primates: will it work and how will we know?
Topics: Aging; Analysis of Variance; Animals; Biomarkers; Body Weight; Cardiovascular Diseases; Cause of Dea | 1999 |
[Neuropsychic effects of dehydroepiandrosterone].
Topics: Affect; Aging; Animals; Attention; Cardiovascular Diseases; Dehydroepiandrosterone; Dehydroepiandros | 2001 |
Dehydroepiandrosterone and dehydroepiandrosterone sulfate: their relation to cardiovascular disease.
Topics: Adolescent; Adult; Aged; Aging; Animals; Arteriosclerosis; Biomarkers; Cardiovascular Diseases; Case | 1991 |
4 trials available for dehydroepiandrosterone and Cardiovascular Diseases
| Article | Year |
|---|---|
Associations between blood sex steroid concentrations and risk of major adverse cardiovascular events in healthy older women in Australia: a prospective cohort substudy of the ASPREE trial.
Topics: Adult; Aged; Australia; Cardiovascular Diseases; Dehydroepiandrosterone; Female; Gonadal Steroid Hor | 2022 |
Association between circulating endogenous androgens and insulin sensitivity changes with exercise training in midlife women.
Topics: Adult; Androgens; Blood Glucose; Body Composition; Cardiovascular Diseases; Cholesterol; Dehydroepia | 2014 |
Effects of dehydroepiandrosterone (DHEA) on cardiovascular risk factors in older women with frailty characteristics.
Topics: Abdominal Fat; Aged; Aged, 80 and over; Blood Glucose; Blood Pressure; Body Composition; Calcium; Ca | 2010 |
Different effect of hormone replacement therapy, DHEAS and tibolone on endothelial function in postmenopausal women with increased cardiovascular risk.
Topics: Brachial Artery; Cardiovascular Diseases; Cross-Over Studies; Dehydroepiandrosterone; Double-Blind M | 2005 |
34 other studies available for dehydroepiandrosterone and Cardiovascular Diseases
| Article | Year |
|---|---|
Parity History and Later Life Sex Hormone Levels in the Multi-Ethnic Study of Atherosclerosis (MESA).
Topics: Androgens; Atherosclerosis; Cardiovascular Diseases; Cross-Sectional Studies; Dehydroepiandrosterone | 2022 |
Dehydroepiandrosterone Sulfate and Mortality in Middle-Aged and Older Men and Women-A J-shaped Relationship.
Topics: Aged; Cardiovascular Diseases; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Female; Human | 2023 |
Dehydroepiandrosterone Sulfate and Mortality in Middle-Aged and Older Men and Women-A J-shaped Relationship.
Topics: Aged; Cardiovascular Diseases; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Female; Human | 2023 |
Dehydroepiandrosterone Sulfate and Mortality in Middle-Aged and Older Men and Women-A J-shaped Relationship.
Topics: Aged; Cardiovascular Diseases; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Female; Human | 2023 |
Dehydroepiandrosterone Sulfate and Mortality in Middle-Aged and Older Men and Women-A J-shaped Relationship.
Topics: Aged; Cardiovascular Diseases; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Female; Human | 2023 |
Is the 1mg-dexamethasone suppression test a precise marker of glucocorticoid excess and cardiometabolic risk in patients with adrenal incidentalomas?
Topics: Adrenal Gland Neoplasms; Cardiovascular Diseases; Cortisone; Cross-Sectional Studies; Dehydroepiandr | 2023 |
Plasma lipoproteins in posttraumatic stress disorder patients compared to healthy controls and their associations with the HPA- and HPT-axis.
Topics: Adult; Cardiovascular Diseases; Case-Control Studies; Cholesterol, HDL; Cholesterol, LDL; Cross-Sect | 2017 |
High Androgens in Postmenopausal Women and the Risk for Atherosclerosis and Cardiovascular Disease: The Rotterdam Study.
Topics: Aged; Aged, 80 and over; Androgens; Androstenedione; Atherosclerosis; Calcium; Cardiovascular Diseas | 2018 |
The possible role of stress induced hormonal disbalance in the patophysiology of insulin resistane in lean individuals.
Topics: Adiposity; alpha 1-Antitrypsin; Blood Glucose; Body Weight; Cardiovascular Diseases; Dehydroepiandro | 2018 |
Endogenous Sex Hormones and Incident Cardiovascular Disease in Post-Menopausal Women.
Topics: Aged; Biomarkers; Cardiovascular Diseases; Cohort Studies; Dehydroepiandrosterone; Estradiol; Female | 2018 |
Dehydroepiandrosterone and Cardiovascular Disease.
Topics: Cardiovascular Diseases; Cardiovascular Physiological Phenomena; Dehydroepiandrosterone; Dehydroepia | 2018 |
Impact of physical or sexual childhood abuse on plasma DHEA, DHEA-S and cortisol in a low-dose dexamethasone suppression test and on cardiovascular risk parameters in adult patients with major depression or anxiety disorders.
Topics: Adrenal Cortex Hormones; Adult; Adult Survivors of Child Abuse; Anxiety Disorders; Cardiovascular Di | 2018 |
The Steroid Profile of Adrenal Incidentalomas: Subtyping Subjects With High Cardiovascular Risk.
Topics: Adrenal Gland Neoplasms; Aged; Cardiovascular Diseases; Chromatography, Liquid; Corticosterone; Cort | 2019 |
Mental health consequences of stress and trauma: allostatic load markers for practice and policy with a focus on Indigenous health.
Topics: Algorithms; Allostasis; Australia; Biomarkers; Cardiovascular Diseases; Comorbidity; Dehydroepiandro | 2015 |
Dehydroepiandrosterone-sulfate is associated with cardiovascular reactivity to stress in women.
Topics: Adult; Age Factors; Blood Flow Velocity; Blood Pressure; Cardiovascular Diseases; Cardiovascular Phy | 2016 |
DHEA, important source of sex steroids in men and even more in women.
Topics: Adrenal Glands; Age Factors; Aging; Anticarcinogenic Agents; Brain; Breast; Cardiovascular Diseases; | 2010 |
Low serum levels of dehydroepiandrosterone sulfate predict all-cause and cardiovascular mortality in elderly Swedish men.
Topics: Aged; Aged, 80 and over; Cardiovascular Diseases; Cause of Death; Cohort Studies; Dehydroepiandroste | 2010 |
Correlation of circulating dehydroepiandrosterone with activated protein C generation and carotid intima-media thickness in male patients with type 2 diabetes.
Topics: Adult; Aged; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Carotid Intima-Media Thickness | 2012 |
On call. My wife and I are both 62 and healthy. She started taking Prempro during her menopause eight years ago but has now decided to stop the hormones. I began taking DHEA five years ago, but I switched to AndroGel when my doctor gave me a prescription
Topics: Aging; Bone Density; Cardiovascular Diseases; Dehydroepiandrosterone; Female; Hormone Replacement Th | 2003 |
Androgen and SHBG serum concentrations in late post-menopause women.
Topics: Adult; Aged; Androgens; Androstenedione; Cardiovascular Diseases; Dehydroepiandrosterone; Dehydroepi | 2003 |
Psychological well-being and ill-being: do they have distinct or mirrored biological correlates?
Topics: Aged; Aged, 80 and over; Biomarkers; Cardiovascular Diseases; Dehydroepiandrosterone; Depression; Fe | 2006 |
Sex hormones, sex hormone binding globulin, and abdominal aortic calcification in women and men in the multi-ethnic study of atherosclerosis (MESA).
Topics: Aged; Aged, 80 and over; Aorta, Abdominal; Atherosclerosis; Cardiovascular Diseases; Cohort Studies; | 2008 |
Lipoprotein(a) levels in girls with premature adrenarche.
Topics: Adolescent; Adrenarche; Blood Glucose; Cardiovascular Diseases; Child; Dehydroepiandrosterone; Femal | 2008 |
Relation of sex hormones and dehydroepiandrosterone sulfate (DHEA-SO4) to cardiovascular risk factors in postmenopausal women.
Topics: Adult; Aged; Aged, 80 and over; Blood Pressure; Cardiovascular Diseases; Cholesterol; Dehydroepiandr | 1995 |
[The relationship between serum dehydroepiandrosterone sulfate levels and factors associated with cardiovascular diseases: a cross-sectional study in Japan].
Topics: Adult; Cardiovascular Diseases; Cross-Sectional Studies; Dehydroepiandrosterone; Female; Humans; Jap | 1995 |
Dehydroepiandrosterone sulfate does not predict cardiovascular death in postmenopausal women. The Rancho Bernardo Study.
Topics: Age Factors; Aged; California; Cardiovascular Diseases; Dehydroepiandrosterone; Dehydroepiandrostero | 1995 |
Lack of association between sex hormones and Lp(a) concentrations in American and Finnish men.
Topics: Adult; Arteriosclerosis; Cardiovascular Diseases; Dehydroepiandrosterone; Dehydroepiandrosterone Sul | 1994 |
The epidemiology of DHEAS and cardiovascular disease.
Topics: Adult; Aged; California; Cardiovascular Diseases; Dehydroepiandrosterone; Dehydroepiandrosterone Sul | 1995 |
DHEA: a biologic conundrum.
Topics: Aging; Alzheimer Disease; Cardiovascular Diseases; Dehydroepiandrosterone; Erectile Dysfunction; Fem | 1998 |
Relation of dehydroepiandrosterone and dehydroepiandrosterone sulfate with cardiovascular disease risk factors in women: longitudinal results from the Massachusetts Women's Health Study.
Topics: Aged; Cardiovascular Diseases; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Female; Human | 1999 |
Metabolic abnormalities related to cardiovascular risk in primary hyperparathyroidism: effects of surgical treatment.
Topics: Cardiovascular Diseases; Dehydroepiandrosterone; Humans; Hyperparathyroidism; Parathyroid Hormone; R | 1999 |
Adult cardiovascular risk factors in premature babies.
Topics: Adult; Birth Weight; Cardiovascular Diseases; Dehydroepiandrosterone; Female; Fetal Growth Retardati | 2000 |
[Diseases in the climacteric, with poor or without any organic findings].
Topics: Cardiovascular Diseases; Climacteric; Dehydroepiandrosterone; Estradiol; Estrogens; Female; Humans; | 1975 |
Lower endogenous androgens predict central adiposity in men.
Topics: Adult; Aged; Androgens; Androstenedione; Body Constitution; Body Mass Index; Cardiovascular Diseases | 1992 |
Serum androgens in intensive-care patients: correlations with clinical findings.
Topics: 17-alpha-Hydroxypregnenolone; 17-alpha-Hydroxyprogesterone; Adrenal Glands; Adult; Androgens; Andros | 1991 |
A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease.
Topics: Aged; Aging; Analysis of Variance; Cardiovascular Diseases; Coronary Disease; Dehydroepiandrosterone | 1986 |
Absence of an inverse relation of dehydroepiandrosterone sulfate with cardiovascular mortality in postmenopausal women.
Topics: Aged; Cardiovascular Diseases; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Female; Human | 1987 |